The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia

NCT00206947 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped No more funding

Conditions

Schizophrenia

Interventions

DRUG: donepezil (5-10 mg/day)
DRUG: Placebo

Sponsor

Birte Glenthoj

Collaborators

[object Object]
[object Object]
[object Object]